Kwang Dong Pharmaceutical Co., Ltd. (KOSE:A009290) agreed to acquire a 58.73% stake in BL Healthcare Corp. (XKON:A086220) from BL Healthcare Corp. (XKON:A086220) for KRW 30 billion on December 29, 2023.